European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis

The European Association for the Study of the Liver has recently updated guidance on haemochromatosis with a more extensive discussion on investigation and management.[ The new guidance focuses on non-invasive methods for fibrosis assessment and early diagnosis to include more extensive genetic test...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Frontline gastroenterology 2023-03, Vol.14 (4), p.282-286
Hauptverfasser:	Cathcart, Jennifer, Mukhopadhya, Ashis
Format:	Artikel
Sprache:	eng
Schlagworte:	Liver
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	286
container_issue	4
container_start_page	282
container_title	Frontline gastroenterology
container_volume	14
creator	Cathcart, Jennifer Mukhopadhya, Ashis
description	The European Association for the Study of the Liver has recently updated guidance on haemochromatosis with a more extensive discussion on investigation and management.[ The new guidance focuses on non-invasive methods for fibrosis assessment and early diagnosis to include more extensive genetic testing if needed. Early diagnosis and treatment is vital as it reduces morbidity and mortality. We review this guideline and offer key updated messages with a focus on new developments since the last guidance and key aspects of current practice.
doi_str_mv	10.1136/flgastro-2022-102296
format	Article
fullrecord	<record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11138169</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_11138169</sourcerecordid><originalsourceid>FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_111381693</originalsourceid><addsrcrecordid>eNqlT7FOwzAUtBCIVrR_wPBGGAKxnaRkQhUKYuhW9ujVcZKHEr_Idir178mAkJi54e50T--kE-Jepk9S6uK5HToM0XOiUqUSuVBZXIm1SjOZZDLLr3-93q3ENoSvdIHWMs-zW7HSuywttVZrYarZ82TRwT4ENoSR2EHLHo5xbi7ALcTewoHO1sNDtT8eHsEM5MjgAJNHE8lY6GZq7JLaAMt3j3Zk03seMXKgsBE3LQ7Bbn_0Try-V59vH8k0n0bbGOuix6GePI3oLzUj1X8vjvq643Mtl-0vsij1_xu-AVuMaBY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Cathcart, Jennifer ; Mukhopadhya, Ashis</creator><creatorcontrib>Cathcart, Jennifer ; Mukhopadhya, Ashis</creatorcontrib><description>The European Association for the Study of the Liver has recently updated guidance on haemochromatosis with a more extensive discussion on investigation and management.[ The new guidance focuses on non-invasive methods for fibrosis assessment and early diagnosis to include more extensive genetic testing if needed. Early diagnosis and treatment is vital as it reduces morbidity and mortality. We review this guideline and offer key updated messages with a focus on new developments since the last guidance and key aspects of current practice.</description><identifier>ISSN: 2041-4137</identifier><identifier>EISSN: 2041-4145</identifier><identifier>DOI: 10.1136/flgastro-2022-102296</identifier><identifier>PMID: 37409332</identifier><language>eng</language><publisher>BMA House, Tavistock Square, London, WC1H 9JR: BMJ Publishing Group</publisher><subject>Liver</subject><ispartof>Frontline gastroenterology, 2023-03, Vol.14 (4), p.282-286</ispartof><rights>Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ. 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11138169/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11138169/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Cathcart, Jennifer</creatorcontrib><creatorcontrib>Mukhopadhya, Ashis</creatorcontrib><title>European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis</title><title>Frontline gastroenterology</title><description>The European Association for the Study of the Liver has recently updated guidance on haemochromatosis with a more extensive discussion on investigation and management.[ The new guidance focuses on non-invasive methods for fibrosis assessment and early diagnosis to include more extensive genetic testing if needed. Early diagnosis and treatment is vital as it reduces morbidity and mortality. We review this guideline and offer key updated messages with a focus on new developments since the last guidance and key aspects of current practice.</description><subject>Liver</subject><issn>2041-4137</issn><issn>2041-4145</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqlT7FOwzAUtBCIVrR_wPBGGAKxnaRkQhUKYuhW9ujVcZKHEr_Idir178mAkJi54e50T--kE-Jepk9S6uK5HToM0XOiUqUSuVBZXIm1SjOZZDLLr3-93q3ENoSvdIHWMs-zW7HSuywttVZrYarZ82TRwT4ENoSR2EHLHo5xbi7ALcTewoHO1sNDtT8eHsEM5MjgAJNHE8lY6GZq7JLaAMt3j3Zk03seMXKgsBE3LQ7Bbn_0Try-V59vH8k0n0bbGOuix6GePI3oLzUj1X8vjvq643Mtl-0vsij1_xu-AVuMaBY</recordid><startdate>20230315</startdate><enddate>20230315</enddate><creator>Cathcart, Jennifer</creator><creator>Mukhopadhya, Ashis</creator><general>BMJ Publishing Group</general><scope>5PM</scope></search><sort><creationdate>20230315</creationdate><title>European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis</title><author>Cathcart, Jennifer ; Mukhopadhya, Ashis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmedcentral_primary_oai_pubmedcentral_nih_gov_111381693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Liver</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cathcart, Jennifer</creatorcontrib><creatorcontrib>Mukhopadhya, Ashis</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Frontline gastroenterology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cathcart, Jennifer</au><au>Mukhopadhya, Ashis</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis</atitle><jtitle>Frontline gastroenterology</jtitle><date>2023-03-15</date><risdate>2023</risdate><volume>14</volume><issue>4</issue><spage>282</spage><epage>286</epage><pages>282-286</pages><issn>2041-4137</issn><eissn>2041-4145</eissn><abstract>The European Association for the Study of the Liver has recently updated guidance on haemochromatosis with a more extensive discussion on investigation and management.[ The new guidance focuses on non-invasive methods for fibrosis assessment and early diagnosis to include more extensive genetic testing if needed. Early diagnosis and treatment is vital as it reduces morbidity and mortality. We review this guideline and offer key updated messages with a focus on new developments since the last guidance and key aspects of current practice.</abstract><cop>BMA House, Tavistock Square, London, WC1H 9JR</cop><pub>BMJ Publishing Group</pub><pmid>37409332</pmid><doi>10.1136/flgastro-2022-102296</doi></addata></record>
fulltext	fulltext
identifier	ISSN: 2041-4137
ispartof	Frontline gastroenterology, 2023-03, Vol.14 (4), p.282-286
issn	2041-4137 2041-4145
language	eng
recordid	cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11138169
source	Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects	Liver
title	European Association for Study of the Liver (EASL) clinical practice guidelines on haemochromatosis
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T14%3A23%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=European%20Association%20for%20Study%20of%20the%20Liver%20(EASL)%20clinical%20practice%20guidelines%20on%20haemochromatosis&rft.jtitle=Frontline%20gastroenterology&rft.au=Cathcart,%20Jennifer&rft.date=2023-03-15&rft.volume=14&rft.issue=4&rft.spage=282&rft.epage=286&rft.pages=282-286&rft.issn=2041-4137&rft.eissn=2041-4145&rft_id=info:doi/10.1136/flgastro-2022-102296&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_11138169%3C/pubmedcentral%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37409332&rfr_iscdi=true